RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OTLK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Outlook Therapeutics Inc. stock price ended at $8.92 on Tuesday, after losing 1.98%.
(Updated on Apr 30, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 20.46% PDF

The Outlook Therapeutics Inc. stock price fell by -1.98% on the last day (Tuesday, 30th Apr 2024) from $9.10 to $8.92. During the last trading day the stock fluctuated 5.09% from a day low at $8.84 to a day high of $9.29. The price has fallen in 6 of the last 10 days but is still up by 1.94% over the past 2 weeks. Volume has increased on the last day by 57 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 203 thousand shares were bought and sold for approximately $1.82 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 307.15% during the next 3 months and, with a 90% probability hold a price between $27.97 and $66.38 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OTLK Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -25.29%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Outlook Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.45 and $8.16. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Outlook Therapeutics Inc. stock

Outlook Therapeutics Inc. finds support from accumulated volume at $8.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.450 between high and low, or 5.09%. For the last week, the stock has had daily average volatility of 6.75%.

Our recommended stop-loss: $8.56 (-4.03%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (OTLK) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Outlook Therapeutics Inc. to open at $9.02, and during the day (based on 14 day Average True Range), to move between $8.12 and $9.72, which gives a possible trading interval of +/-$0.796 (+/-8.92%) up or down from last closing price. If Outlook Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 17.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.63 (3.25%) than the resistance at $9.37 (5.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Outlook Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.503 Buy Candidate Unchanged

Predicted Opening Price for Outlook Therapeutics Inc. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$9.02 ( 1.08%) $8.92

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OTLK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.47 6.13 %
R2 9.29 4.20 %
R1 9.19 3.01 %
Current price: 8.92
Support S1 8.84 -0.84 %
S2 8.74 -2.03 %
S3 8.57 -3.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.26 15.02 %
R2 9.70 8.74 %
R1 9.37 5.04 %
Current price 8.92
Support S1 8.63 -3.25%
S2 8.51 -4.60%
S3 8.24 -7.62%

FAQ

What is the symbol for Outlook Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Outlook Therapeutics Inc. is OTLK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Outlook Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

How to buy Outlook Therapeutics Inc. Stock?
Outlook Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Outlook Therapeutics Inc. Stock.

What's the current price of Outlook Therapeutics Inc. Stock?
As of the end of day on the Apr 30, 2024, the price of an Outlook Therapeutics Inc. (OTLK) share was $8.92.

What is the 52-week high and low for Outlook Therapeutics Inc. Stock?
The 52-week high for Outlook Therapeutics Inc. Stock is $12.85 and the 52-week low is $0.200.

What is the market capitalization of Outlook Therapeutics Inc. Stock?
As of the Apr 30, 2024, the market capitalization of Outlook Therapeutics Inc. is 196.417M.

When is the next earnings date for Outlook Therapeutics Inc.?
The upcoming earnings date for Outlook Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT